Ifosfamide-Induced Metabolic Encephalopathy in 2 Patients With Cutaneous T-Cell Lymphoma Successfully Treated With Methylene Blue

Ifosfamide, an alkylating agent used in cancer treatments, can cause neurotoxicity. The clinical presentation can range from mild symptoms such as acute confusion to non-convulsive seizures, severe irreversible coma, and death. The benefit of methylene blue use in treating ifosfamide-induced metabol...

Descripción completa

Detalles Bibliográficos
Autores principales: Vakiti, Anusha, Pilla, Ravi, Alhaj Moustafa, Muhamad, Joseph, Jacinth J., Shenoy, Aarthi G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069036/
https://www.ncbi.nlm.nih.gov/pubmed/30083561
http://dx.doi.org/10.1177/2324709618786769

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6069036/
https://www.ncbi.nlm.nih.gov/pubmed/30083561
http://dx.doi.org/10.1177/2324709618786769

Ejemplares similares